世界のヘレセプチンバイオシミラー市場レポート2020年

QYResearchが発行した調査報告書(QYR21FB6371)
◆英語タイトル:Global Hereceptin Biosimilar Sales Market Report 2020
◆商品コード:QYR21FB6371
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:137
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界のヘレセプチンバイオシミラー市場について種類別(錠剤、カプセル)、用途別(医薬品、医療、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ヘレセプチンバイオシミラー市場の概要
・世界の主要地域別ヘレセプチンバイオシミラー市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のヘレセプチンバイオシミラー市場規模2015-2026:種類別(錠剤、カプセル)
・世界のヘレセプチンバイオシミラー市場規模2015-2026:用途別(医薬品、医療、その他)
・ヘレセプチンバイオシミラーのアメリカ市場規模2015-2020
・ヘレセプチンバイオシミラーのヨーロッパ市場規模2015-2020
・ヘレセプチンバイオシミラーの中国市場規模2015-2020
・ヘレセプチンバイオシミラーの日本市場規模2015-2020
・ヘレセプチンバイオシミラーの東南アジア市場規模2015-2020
・ヘレセプチンバイオシミラーのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ヘレセプチンバイオシミラーの製造コスト分析
・販売チャネル、流通業者、顧客
・ヘレセプチンバイオシミラーの市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Hereceptin Biosimilar Market
The global Hereceptin Biosimilar market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Hereceptin Biosimilar Scope and Market Size
The global Hereceptin Biosimilar market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hereceptin Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Hereceptin Biosimilar market is segmented into
Tablet
Capsule

Segment by Application, the Hereceptin Biosimilar market is segmented into
Pharmaceuticals
Healthcare
Others

The Hereceptin Biosimilar market is analysed and market size information is provided by regions (countries). Segment by Application, the Hereceptin Biosimilar market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Hereceptin Biosimilar Market Share Analysis
Hereceptin Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereceptin Biosimilar business, the date to enter into the Hereceptin Biosimilar market, Hereceptin Biosimilar product introduction, recent developments, etc.

The major vendors covered:
Mylan N.V.
AryoGen Biopharma
Genor Biopharma
Celltrion Inc.
Amgen Inc.
Mabion S.A.
The Instituto Vital Brazil
F. Hoffmann-La Roche AG
Biocon
Gedeon Richter Plc

【レポートの目次】

1 Hereceptin Biosimilar Market Overview
1.1 Hereceptin Biosimilar Product Scope
1.2 Hereceptin Biosimilar Segment by Type
1.2.1 Global Hereceptin Biosimilar Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Capsule
1.3 Hereceptin Biosimilar Segment by Application
1.3.1 Global Hereceptin Biosimilar Sales Comparison by Application (2020-2026)
1.3.2 Pharmaceuticals
1.3.3 Healthcare
1.3.4 Others
1.4 Hereceptin Biosimilar Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hereceptin Biosimilar Sales Growth Rate (2015-2026)
1.4.2 Global Hereceptin Biosimilar Revenue and Growth Rate (2015-2026)
1.4.3 Global Hereceptin Biosimilar Price Trends (2015-2026)

2 Hereceptin Biosimilar Estimate and Forecast by Region
2.1 Global Hereceptin Biosimilar Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hereceptin Biosimilar Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hereceptin Biosimilar Sales Market Share by Region (2015-2020)
2.2.2 Global Hereceptin Biosimilar Revenue Market Share by Region (2015-2020)
2.3 Global Hereceptin Biosimilar Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hereceptin Biosimilar Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hereceptin Biosimilar Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.2 Europe Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.3 China Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.4 Japan Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.6 India Hereceptin Biosimilar Estimates and Projections (2015-2026)
3 Global Hereceptin Biosimilar Competition Landscape by Players
3.1 Global Top Hereceptin Biosimilar Players by Sales (2015-2020)
3.2 Global Top Hereceptin Biosimilar Players by Revenue (2015-2020)
3.3 Global Hereceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereceptin Biosimilar as of 2019)
3.4 Global Hereceptin Biosimilar Average Price by Company (2015-2020)
3.5 Manufacturers Hereceptin Biosimilar Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hereceptin Biosimilar Players (Opinion Leaders)
4 Global Hereceptin Biosimilar Market Size by Type
4.1 Global Hereceptin Biosimilar Historic Market Review by Type (2015-2020)
4.1.1 Global Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
4.1.2 Global Hereceptin Biosimilar Revenue Market Share by Type (2015-2020)
4.1.3 Global Hereceptin Biosimilar Price by Type (2015-2020)
4.2 Global Hereceptin Biosimilar Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hereceptin Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Hereceptin Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Global Hereceptin Biosimilar Price Forecast by Type (2021-2026)
5 Global Hereceptin Biosimilar Market Size by Application
5.1 Global Hereceptin Biosimilar Historic Market Review by Application (2015-2020)
5.1.1 Global Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
5.1.2 Global Hereceptin Biosimilar Revenue Market Share by Application (2015-2020)
5.1.3 Global Hereceptin Biosimilar Price by Application (2015-2020)
5.2 Global Hereceptin Biosimilar Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hereceptin Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Hereceptin Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Hereceptin Biosimilar Price Forecast by Application (2021-2026)

6 United States Hereceptin Biosimilar Market Facts & Figures
6.1 United States Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
6.2 United States Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
6.3 United States Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

7 Europe Hereceptin Biosimilar Market Facts & Figures
7.1 Europe Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
7.2 Europe Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
7.3 Europe Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

8 China Hereceptin Biosimilar Market Facts & Figures
8.1 China Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
8.2 China Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
8.3 China Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

9 Japan Hereceptin Biosimilar Market Facts & Figures
9.1 Japan Hereceptin Biosimilar Sales Market Share by Company (3015-3030)
9.2 Japan Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
9.3 Japan Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

10 Southeast Asia Hereceptin Biosimilar Market Facts & Figures
10.1 Southeast Asia Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

11 India Hereceptin Biosimilar Market Facts & Figures
11.1 India Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
11.2 India Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
11.3 India Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Hereceptin Biosimilar Business
12.1 Mylan N.V.
12.1.1 Mylan N.V. Corporation Information
12.1.2 Mylan N.V. Business Overview
12.1.3 Mylan N.V. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Mylan N.V. Hereceptin Biosimilar Products Offered
12.1.5 Mylan N.V. Recent Development
12.2 AryoGen Biopharma
12.2.1 AryoGen Biopharma Corporation Information
12.2.2 AryoGen Biopharma Business Overview
12.2.3 AryoGen Biopharma Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AryoGen Biopharma Hereceptin Biosimilar Products Offered
12.2.5 AryoGen Biopharma Recent Development
12.3 Genor Biopharma
12.3.1 Genor Biopharma Corporation Information
12.3.2 Genor Biopharma Business Overview
12.3.3 Genor Biopharma Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Genor Biopharma Hereceptin Biosimilar Products Offered
12.3.5 Genor Biopharma Recent Development
12.4 Celltrion Inc.
12.4.1 Celltrion Inc. Corporation Information
12.4.2 Celltrion Inc. Business Overview
12.4.3 Celltrion Inc. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Celltrion Inc. Hereceptin Biosimilar Products Offered
12.4.5 Celltrion Inc. Recent Development
12.5 Amgen Inc.
12.5.1 Amgen Inc. Corporation Information
12.5.2 Amgen Inc. Business Overview
12.5.3 Amgen Inc. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amgen Inc. Hereceptin Biosimilar Products Offered
12.5.5 Amgen Inc. Recent Development
12.6 Mabion S.A.
12.6.1 Mabion S.A. Corporation Information
12.6.2 Mabion S.A. Business Overview
12.6.3 Mabion S.A. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mabion S.A. Hereceptin Biosimilar Products Offered
12.6.5 Mabion S.A. Recent Development
12.7 The Instituto Vital Brazil
12.7.1 The Instituto Vital Brazil Corporation Information
12.7.2 The Instituto Vital Brazil Business Overview
12.7.3 The Instituto Vital Brazil Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.7.4 The Instituto Vital Brazil Hereceptin Biosimilar Products Offered
12.7.5 The Instituto Vital Brazil Recent Development
12.8 F. Hoffmann-La Roche AG
12.8.1 F. Hoffmann-La Roche AG Corporation Information
12.8.2 F. Hoffmann-La Roche AG Business Overview
12.8.3 F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.8.4 F. Hoffmann-La Roche AG Hereceptin Biosimilar Products Offered
12.8.5 F. Hoffmann-La Roche AG Recent Development
12.9 Biocon
12.9.1 Biocon Corporation Information
12.9.2 Biocon Business Overview
12.9.3 Biocon Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biocon Hereceptin Biosimilar Products Offered
12.9.5 Biocon Recent Development
12.10 Gedeon Richter Plc
12.10.1 Gedeon Richter Plc Corporation Information
12.10.2 Gedeon Richter Plc Business Overview
12.10.3 Gedeon Richter Plc Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Gedeon Richter Plc Hereceptin Biosimilar Products Offered
12.10.5 Gedeon Richter Plc Recent Development

13 Hereceptin Biosimilar Manufacturing Cost Analysis
13.1 Hereceptin Biosimilar Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hereceptin Biosimilar
13.4 Hereceptin Biosimilar Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hereceptin Biosimilar Distributors List
14.3 Hereceptin Biosimilar Customers

15 Market Dynamics
15.1 Hereceptin Biosimilar Market Trends
15.2 Hereceptin Biosimilar Opportunities and Drivers
15.3 Hereceptin Biosimilar Market Challenges
15.4 Hereceptin Biosimilar Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【掲載企業】

Mylan N.V.、AryoGen Biopharma、Genor Biopharma、Celltrion Inc.、Amgen Inc.、Mabion S.A.、The Instituto Vital Brazil、F. Hoffmann-La Roche AG、Biocon、Gedeon Richter Plc

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のヘレセプチンバイオシミラー市場レポート2020年(Global Hereceptin Biosimilar Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。